Search
for
Sort by
Research 121–150 of 1000+
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- The antiandrogenic effect of finasteride against a mutant androgen receptor
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Faculty Opinions recommendation of The vitamin D receptor is a Wnt effector that controls hair follicle differentiation and specifies tumor type in adult epidermis.
- Genetic Variants and Protective Immunity against SARS-CoV-2
- Microenvironment-Responsive Recombinant Collagen XVII-Based Composite Microneedles for the Treatment of Androgenetic Alopecia
- Autoimmune disorders associated with type 1 diabetes: clinical overview and principles of management
- Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through dermal papilla
- Why steroids may not always work in alopecia areata: elevated unoccupied glucocorticoid receptors and decreased levels of thioredoxin
- A cross sectional study evaluating the relationship of acne to androgenetic alopecia subtype and severity
- The extract of Thujae occidentalis semen inhibited 5α-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse
- Perifollicular Fibrosis: Pathogenetic Role in Androgenetic Alopecia
- Telogen effluvium
- Bacitracin-Loaded Type I Collagen/Bacterial Cellulose Dressing for the Repair of Infected Wounds
- MON-203 Dermatological Effects Of Hormone Replacement Therapy
- The stiffness of the extracellular matrix is a key factor in tumor progression
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study
- Oxidative Activity of the Type 2 Isozyme of 17β-Hydroxysteroid Dehydrogenase (17β-HSD) Predominates in Human Sebaceous Glands
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia
- trans-3,4'-Dimethyl-3-hydroxyflavanone, a Hair Growth Enhancing Active Component, Decreases Active Transforming Growth Factor .BETA.2 (TGF-.BETA.2) through Control of Urokinase-Type Plasminogen Activator (uPA) on the Surface of Keratinocytes
- Synthesis and in vitro study of 17β-[N-ureylene-N,N′-disubstituted]-4-methyl-4-aza-5α-androstan-3-ones as selective inhibitors of type I 5α-reductase
- Chitosan Nanoparticle-Encapsulated Cordyceps militaris Grown on Germinated Rhynchosia nulubilis Reduces Type II Alveolar Epithelial Cell Apoptosis in PM2.5-Induced Lung Injury
- Alopecia and the metabolic syndrome
- Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-<i>N</i>-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Exploring the Inhibitory Potential of Phytosterols β-Sitosterol, Stigmasterol, and Campesterol on 5-Alpha Reductase Activity in the Human Prostate: An In Vitro and In Silico Approach
- Bayesian measurement-error-driven hidden Markov regression model for calibrating the effect of covariates on multistate outcomes: Application to androgenetic alopecia
- Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question